Literature DB >> 16508017

Phosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest.

Annika Järviluoma1, Emma S Child, Grzegorz Sarek, Papinya Sirimongkolkasem, Gordon Peters, Päivi M Ojala, David J Mann.   

Abstract

K cyclin encoded by Kaposi's sarcoma-associated herpesvirus confers resistance to the cyclin-dependent kinase (cdk) inhibitors p16Ink4A, p21Cip1, and p27Kip1 on the associated cdk6. We have previously shown that K cyclin expression enforces S-phase entry on cells overexpressing p27Kip1 by promoting phosphorylation of p27Kip1 on threonine 187, triggering p27Kip1 down-regulation. Since p21Cip1 acts in a manner similar to that of p27Kip1, we have investigated the subversion of a p21Cip1-induced G1 arrest by K cyclin. Here, we show that p21Cip1 is associated with K cyclin both in overexpression models and in primary effusion lymphoma cells and is a substrate of the K cyclin/cdk6 complex, resulting in phosphorylation of p21Cip1 on serine 130. This phosphoform of p21Cip1 appeared unable to associate with cdk2 in vivo. We further demonstrate that phosphorylation on serine 130 is essential for K cyclin-mediated release of a p21Cip1-imposed G1 arrest. Moreover, we show that under physiological conditions of cell cycle arrest due to elevated levels of p21Cip1 resulting from oxidative stress, K cyclin expression enabled S-phase entry and was associated with p21Cip1 phosphorylation and partial restoration of cdk2 kinase activity. Thus, expression of the viral cyclin enables cells to subvert the cell cycle inhibitory function of p21Cip1 by promoting cdk6-dependent phosphorylation of this antiproliferative protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16508017      PMCID: PMC1430279          DOI: 10.1128/MCB.26.6.2430-2440.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.

Authors:  P D Adams
Journal:  Biochim Biophys Acta       Date:  2001-03-21

Review 2.  Viral-encoded cyclins.

Authors:  H Laman; D J Mann; N C Jones
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

3.  Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.

Authors:  Rukiyah Van Dross; Shan Yao; Shaheena Asad; Grant Westlake; Deborah J Mays; Laura Barquero; Stephanie Duell; Jennifer A Pietenpol; Philip J Browning
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506

4.  Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.

Authors:  S C Wong; J K Chan; K C Lee; W L Hsiao
Journal:  J Pathol       Date:  2001-05       Impact factor: 7.996

5.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.

Authors:  B P Zhou; Y Liao; W Xia; B Spohn; M H Lee; M C Hung
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

6.  TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.

Authors:  T Ono; H Kitaura; H Ugai; T Murata; K K Yokoyama; S M Iguchi-Ariga; H Ariga
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines.

Authors:  G M Platt; E Cannell; M E Cuomo; S Singh; S Mittnacht
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

8.  Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells.

Authors:  L Rössig; A S Jadidi; C Urbich; C Badorff; A M Zeiher; S Dimmeler
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

9.  The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity.

Authors:  J M Estanyol; M Jaumot; O Casanovas; A Rodriguez-Vilarrupla; N Agell; O Bachs
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

10.  Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence.

Authors:  E S Child; D J Mann
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

View more
  22 in total

1.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 2.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 3.  Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

Authors:  Antonino Carbone; Ethel Cesarman; Annunziata Gloghini; Hans G Drexler
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

4.  Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition.

Authors:  Tiffany Jones; Suzane Ramos da Silva; Roble Bedolla; Fengchun Ye; Fuchun Zhou; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2014-01-13       Impact factor: 4.534

5.  A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Cyclin-cyclin-dependent kinase regulatory response is linked to substrate recognition.

Authors:  Maria Emanuela Cuomo; Georgina M Platt; Laurence H Pearl; Sibylle Mittnacht
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

7.  Cdk2-dependent phosphorylation of p21 regulates the role of Cdk2 in cisplatin cytotoxicity.

Authors:  Rawad Hodeify; Adel Tarcsafalvi; Judit Megyesi; Robert L Safirstein; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-16

Review 8.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

9.  Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK·cyclin complexes.

Authors:  Anett Marais; Zongling Ji; Emma S Child; Eberhard Krause; David J Mann; Andrew D Sharrocks
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

10.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Authors:  Ludmila Jirmanova; Dandapantula N Sarma; Dragana Jankovic; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.